A second example of anti-Esa, an antibody to a high-incidence Cromer antigen
Reid, M.E., Marfoe, R.A., Mueller, A.L., Arndt, P.A., Sausais, L., Spruell, P.
Review: what to do when all RBCs are incompatible—serologic aspects
Nance, S.T., Arndt, P.A.
Warm autoimmune hemolytic anemia associated with an IgM autoanti-Ge
Sererat, T., Veidt, D., Arndt, P.A., Garratty, G.
First example of an FY*01 allele associated with weakened expression of Fya on red blood cells
Arndt, P.A., Horn, T., Keller, J.A., Young, R., Heri, S.M., Keller, M.A.
Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach
Arndt, P.A.
An update on drug-induced immune hemolytic anemia
Garratty, G., Arndt, P.A.
Utility of chloroquine diphosphate in the blood bank laboratory
Aye, T., Arndt, P.A.
Drug-induced immune hemolytic anemia: the last 30 years of changes
Arndt, P.A.
How we investigate drug-induced immune hemolytic anemia
Leger, R.M., Arndt, P.A., Garratty, G.
Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007
Garratty, G., Arndt, P.A.